POLE and cancer: Indeed, distinct mutational signatures have been observed in human cancers with concomitant POLE exonuclease mutations and MMR deficiency8 and also in Caenorhabditis elegans lines deficient for both the MMR factor pms-2 and the polymerase epsilon subunit pole-49.